跳至主要内容
临床试验/NCT00798382
NCT00798382已完成2 期

Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Term Infants

Abbott Nutrition17 个研究点 分布在 1 个国家目标入组 154 人开始时间: 2008年12月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
154
试验地点
17
主要终点
Gastrointestinal tolerance from Study Visit 1 to Study Visit 3 at 35 days of age.

研究概览

简要总结

The objective of this study is to assess the comparative gastrointestinal (GI) tolerance of normal term infants to two experimental soy-based formulas, relative to a commercially available soy-based formula.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 8 Days(Child)
性别
All
接受健康志愿者
是

入选标准

  • •Infant is judged to be in good health.
  • •Infant is a singleton from a full term birth with a gestational age of 37-42 weeks.
  • •Infant's birth weight was > 2490 g (~5 lb 8 oz).
  • •Infant is between 0 and 8 days of age at enrollment.
  • •Parent(s) confirm their intention to feed their infant the study product as the sole source of nutrition for the duration of the study.
  • •Parent(s) confirm their intention not to administer vitamin or mineral supplements, solid foods or juices to their infant for the duration of the study.
  • •Infants using medications or home remedies, herbal preparations or rehydration/intravenous (IV) fluids that might affect GI tolerance may not be enrolled.

排除标准

  • •An adverse maternal, fetal or infant medical history that is thought by the investigator to have potential for effects on tolerance, growth, and/or development.
  • •Infant has been treated with antibiotics.
  • •Infant has received probiotics.

研究组 & 干预措施

1: Soy formula

Experimental

experimental soy formula #1

干预措施: soy protein formula (Other)

2: Soy Formula

Active Comparator

Commercially available soy formula

干预措施: Commercially available soy formula (Other)

3: Soy formula

Experimental

experimental soy formula #2

干预措施: Soy formula experimental #2 (Other)

结局指标

主要结局

Gastrointestinal tolerance from Study Visit 1 to Study Visit 3 at 35 days of age.

时间窗: 35 days

次要结局

  • Additional gastrointestinal measures of tolerance from Study Visit 1 to Study Visit 3 at 35 days of age(35 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (17)

Loading locations...

相似试验